Introduction
Genetic skin disorders are attractive targets for research and development of gene therapy strategies as the epidermis is accessible and visible. Keratinocytes can be taken ex vivo (from small skin biopsies), cultured, treated and then grafted back to the epidermal site where the outcome of an intervention can be monitored continuously and noninvasively. Similarly, keratinocytes can provide vector cells for gene delivery, locally or systemically. [1] [2] [3] Epidermolysis bullosa simplex (EBS) is an autosomal dominant skin fragility disorder caused by mutations in copolymeric K5 and K14 keratins, [4] [5] [6] the intermediate filament proteins expressed in the basal cells of stratified epithelia. Many different missense mutations in K5 or K14 lead to fragile epidermal basal cells that lyse upon mild physical trauma to produce intraepithelial blisters (recently reviewed by Porter and Lane 7 ). As K5 and K14 will only assemble as heteropolymers, mutation in either one of the genes can compromise the whole filament network. There are different degrees of clinical severity in EBS and this is generally correlated with the position of the alteration in the protein. 8 The Dowling-Meara form (DM-EBS) shows the most severe phenotype, linked to mutation 'hotspots' at the ends of the central a-helical rod domain of each keratin, with especially frequent mutations in the K14 arginine125 codon. This EBS form is characterized by clustered blisters and by abnormal formation of keratin protein aggregates in basal cells. 9 The keratins implicated in EBS are members of the large intermediate filament multigene family. All intermediate filaments have similar secondary and tertiary structure and assemble into cytoplasmic filaments with almost indistinguishable morphology, but they each have differentiation-specific expression ranges that are defined at a very early stage of tissue morphogenesis. This suggests that intermediate filaments have a critical role in defining differentiation. Studies of a range of genetic tissue fragility disorders now suggest that most, if not all, intermediate filament types contribute to the physical resilience of the tissue in which they are expressed.
Cures for genetic disorders require reprogramming of the genetic profile of the affected cells. In developing gene therapy strategies for dominant disorders like EBS, it is generally taken that the dominant mutant gene will need to be silenced in order to correct the pathological phenotype. Many different therapeutic strategies are being investigated, including chimaeric RNA/DNA oligonucleotides 10 and triplex-forming oligonucleotides, [11] [12] [13] small-fragment homologous replacement, 14 antisense technology, 15 small interfering RNAs (siRNAs) 16, 17 and ribozyme technology, 18, 19 with varying success. A final obstacle is that most EBS mutations are individual and differ from patient to patient so that gene repair/deletion strategies would require unique molecular biology manipulation for each family.
Building on previous observations, 20 we investigated an alternative approach to gene therapy for EBS that involves reinforcing the faulty system function without trying to repair the gene directly. EBS skin blistering is localized and irregular, suggesting that the keratinocytes are almost strong enough to withstand normal physical stress. We therefore hypothesized that a modest amount of structural reinforcement of the keratin network might be sufficient to allow the cells to function normally. 20 The type III intermediate filament protein desmin is a homopolymeric protein normally expressed in muscle cells that, like epidermal keratinocytes, are subject to physical stress. While keratin filaments are type I/type II heteropolymers, desmin assembles as a type III homopolymer. We previously showed that a transfected hamster desmin protein did not copolymerize with keratins and appeared unaffected by mutant keratins in the same cell. 20 Here, we report the results of recently developed functional assays on 'severe' keratin mutant DM-EBS cells after transfection with human desmin.
Transfected human desmin is filamentous and remains independent of keratin filaments
The ability of transfected desmin to make filaments can be seen in SW13, adrenal cortex adenocarcinoma cells, which do not normally express any cytoplasmic intermediate filament proteins 21, 22 ( Figure 1c ). KEB-7 cells, 25 which express a highly disruptive keratin mutation (K14 R125P), typical of the severe Dowling-Meara type EBS, were stably transfected with full-length human desmin cDNA, using a retroviral vector (pKDblast) ( Figure 1a 
Response to osmotic shock
Following hypo-osmotic shock with 150 mM urea, cells respond to the transient swelling by the activation of the stress-activated protein kinase (JNK/SAPK) pathway. Cells expressing mutant keratins react with an earlier activation of this pathway. 27 We tested the effect of desmin supplementation on SAPK activation in KEB-7.Des cells compared to wild-type (NEB-1) and nontransfected mutant cells (KEB-7). In KEB-7 cells, JNK activation is visible 2.5 min after stress, whereas in KEB-7.Des cells, the stress response to osmotic shock is reduced to near control levels and phosphorylated pJNK or pATF-2 bands are not detectable until 5 min after the stress (Figure 3 ).
Scratch wound closure
The rate of closure of a tissue culture scratch 'wound' can be used to demonstrate comparative rates of cell mobilization and migration. Cells expressing EBS-associated keratin mutations show faster scratch wound closure than wild-type cells, 25 possibly a consequence of the constitutively stressed state of the mutant cells which has the effect of priming them for a wound response. We examined the effect of desmin supplementation on this surrogate indicator of epithelial wound healing. By 8 h after scratch wounding, the KEB-7 cells have covered nearly three times the area covered by wild-type cells (Figure 4 ; Po0.001). Desmin-supplemented KEB-7.Des cells, however, show a highly significant reduction in their scratch wound coverage (Po0.001), which is down to half the KEB-7 value and approaching that of the wild-type cells.
Heat shock
Brief exposure of cells to elevated temperature (431C for 5 min) reveals an increased thermoinstability in the mutant keratin filaments over wild-type cells, probably due to a reduced affinity interaction between keratin subunits at some stage of filament assembly or turnover. 28 In previous studies, keratin aggregates were transiently observed after heat shock in cells expressing mutant keratins but not in cells with normal keratins 26, 28 ( Figure 5a ). However, when KEB-7.Des cells were tested, no aggregates were detected, either in the keratin (Figure  5b ) or in the desmin networks (data not shown). . Vectors without desmin inserts served as negative controls. Retroviral particles were generated by transfecting vectors into Phoenix amphotropic packaging cells 24 using calcium phosphate. 23 Culture supernatants containing viral particles were collected after 48 h, filtered and used to infect KEB-7 cells at 20-30% confluence. At 24 h after infection, retroviral supernatant was replaced with fresh medium and cells left to grow for 5 days. Transfected cells were then selected with 5 mg/ml of blasticidin (Invitrogen Life Technologies) for 5 days, resulting in a 95% transfection-positive culture. Stable desmin-transfected KEB-7 cells are referred to as KEB-7.Des. Keratinocyte culture conditions were as described previously. 25 (b) Desmin and K14 expression levels in KEB-7 (a), KEB-7.Des (b) and wild-type NEB-1 (c) were detected by immunoblotting with NCL-DES-DERII mouse monoclonal antibody against desmin (Novocastra; dilution 1:100, track B) and LL001 mouse monoclonal antibody to K14. 26 The expression levels of endogenous K14 and transfected desmin are comparable (b). (c) Human desmin is able to form filaments in the absence of keratins. SW13 adenocarcinoma cells, lacking any cytoplasmic intermediate filament system, 21, 22 were transiently transfected with the desmin and the expressed protein localized with the antibody to desmin NCL-DES-DERII. The human desmin is able to form well-defined filaments de novo, which tend to concentrate close to the nucleus. SW13 cells were grown in DMEM with 10% FCS. Scale bar ¼ 15 mm.
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Thus in three separate functional assays that measure different aspects of epithelial cell behaviour, the addition of human desmin to a keratinocyte cell line expressing a severe EBS-associated keratin mutation has led to a nearcomplete rescue of phenotype. This is the first functional study to test the efficacy of intermediate filament supplementation therapy. It is a significant advance on our earlier experiments, in which we used a mildly mutated EBS cell line (KEB-3 cells, K14-V270M) supplemented with hamster desmin and showed that the desmin formed independent filaments from the keratins. 20 The present study also incorporates two significant refinements -the use of human rather than hamster desmin and the use of a cell line derived from DowlingMeara EBS patient (the disease form that will undoubtedly produce the greatest urgency for treatment) -that bring this concept closer to application for human disease. In another recent study, hamster desmin was introduced into basal keratinocytes in a fatally severe mouse model of EBS, a K5 null mouse. 29 While desmin still appeared to have no detrimental effects, no phenotypic rescue was achieved either, possibly because expression levels of desmin were much lower than in the present study. However, as no K5 null has ever been found in humans, this extremely severe model is probably inappropriate for developing EBS therapy.
Muscle desmin as a supplement for EBS keratinocytes
Desmin is the gene of choice for supplementation of epidermal keratin defects, because it is known to be an essential reinforcing component of muscle 30 and so may be able to reinforce physically the fragile epidermal keratinocytes of EBS. Secondly, because desmin can form homopolymers and is not expected to interact with keratins, [31] [32] [33] desmin filaments should not be vulnerable to the dominant-negative effects of mutant keratins. 
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These presuppositions would appear to be correct, as the expression of desmin in EBS cells does indeed have an effect of countering the accelerated or upregulated stress responses that are characteristic of EBS-derived cell lines. The lack of interaction of desmin with desmosomes in these transfected keratinocytes, which might be due to a lower affinity of desmin for desmosomes in epithelia than in muscle, suggests that desmosome binding is not an essential requirement for a second filament system to reinforce the defective keratinocytes. The beneficial effect of a noninteracting filament network must be mediated by some other properties of the system. The mechanism by which desmin partially rescues mutant keratin cells remains to be determined. Mechanosensory signalling is still poorly understood, but it is known that growth and differentiation of skeletal muscle take place in response to mechanical stress generated during normal movement and exercise. The intermediate filament network, espe- Figure 3 Supplementation with desmin reduces levels of activation of the stress-activated kinase signalling pathway. Having previously shown that levels of JNK/SAPK and ATF-2 phosphorylation are elevated in EBS cells after hypo-osmotic shock, 27 we carried out the same experiment on cells supplemented with human desmin. KEB-7, KEB-7.Des and NEB-1 (control) cells were exposed to hypo-osmotic shock for 5 min at 371C in 150 mM urea as described previously 27 and then returned to normal culture medium for various recovery periods. Levels of JNK, pJNK and pATF-2 were determined by immunoblotting with specific antibodies to JNK/SAPK, pJNK/SAPK and pATF-2 (New England Biolabs). Total JNK1 (46 kDa), JNK2 (54 kDa), phosphorylated JNK (pJNK1, pJNK2) and pATF-2 (a target of JNK) were analysed by immunoblotting before and after hypo-osmotic shock. KEB-7.Des cells are slower to activate JNK/ SAPK and ATF-2 than KEB-7: phosphorylated kinase bands appear in KEB-7 cells at 2.5 min after osmotic shock, but not until 5 min in KEB-7.Des and 10 min in control NEB-1 cells, indicating that desmin supplementation has shifted the EBS cells' response towards the wildtype behaviour. Figure 4 Desmin restores cell behaviour in scratch wound assays. KEB-7, KEB-7.Des and NEB1 cell lines were plated in 24-well plates and grown to confluence over 5 days. Simple scratch wounds were made in all wells using a yellow Gilson pipette tip. In all, 12 wells were fixed with methanol:acetone (1:1) at the time of scratching and the rest after 8 h of continued growth. The wound area was microscopically measured using AxioVision 3.0 software (Carl Zeiss Vision GmbH), and the reduction in scratch wound area over the 8 h was calculated. 25 The extent of scratch wound closure was measured as the reduction of the scratch area after 8 h. Images above show phase-contrast micrographs of the extent of scratch values for each cell line (n ¼ 48). KEB-7 cells migrate most quickly into the scratch area; KEB-7.Des wound closure is significantly slower and approaches the speed of the wild-type NEB-1 cells. Scale bar ¼ 50 mm. Figure 5 Desmin normalize cell response to heath shock. KEB-7 and KEB-7.Des cells were grown to 80% confluence on 13 mm microscope coverslips and subjected to heat shock at 431C for 15 min as described previously. 25, 28 The cells were then returned to 371C for 15 min and fixed and stained for K5 using BL18 antibody, diluted 1:200. The keratin network of KEB-7 has numerous tiny aggregates (a and inset) that are absent in the rescued KEB-7.Des cells (b and inset). Scale bar ¼ 15 mm.
Rescue of EBS cells by supplementation with desmin M D'Alessandro et al cially desmin, could be a potential candidate in this mechanosensory transcription process. 34 In muscle, both mechanical stretch and contraction cause robust increase in desmin mRNA content within 6-10 h, and this induction seems to be controlled at the transcriptional level. 35 Epithelial cells such as keratinocytes are also known to respond to stretch signals with growth and proliferation. [36] [37] [38] Potential impact of supplementation therapy
The idea of supplementing mutant keratin cells with desmin is a potentially powerful approach, as it may bypass the need for a specific gene therapy design for each individual keratin mutation. One desmin transfection should be effective for all the EBS mutations. Further experiments are now required to understand the mechanisms by which this improvement is effected, as well as to investigate the simplest way of inducing desmin expression in skin cells, taking into account that much is now known about desmin gene regulation. [39] [40] [41] The concept of supplementation therapy may have a much wider applicability to a range of genetic disorders involving polymerizing structural proteins, irrespective of the specific disease mutation carried. If the induction or introduction of one extra gene could be used to improve many related disorders with similar but discrete mutations, supplementation therapy may be able to overcome some of the significant financial obstacles facing the development of gene therapy strategies. This is particularly important for the growing number of known but rare diseases, in which any commercial market for gene therapy will always remain small.
